BR9915605A - Uso de derivados do ácido fosfonofórmico para o tratamento de infecções - Google Patents

Uso de derivados do ácido fosfonofórmico para o tratamento de infecções

Info

Publication number
BR9915605A
BR9915605A BR9915605-9A BR9915605A BR9915605A BR 9915605 A BR9915605 A BR 9915605A BR 9915605 A BR9915605 A BR 9915605A BR 9915605 A BR9915605 A BR 9915605A
Authority
BR
Brazil
Prior art keywords
derivatives
treat infections
phosphonoformic acid
infections
treatment
Prior art date
Application number
BR9915605-9A
Other languages
English (en)
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of BR9915605A publication Critical patent/BR9915605A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"USO DE DERIVADOS DO áCIDO FOSFONOFóRMICO PARA O TRATAMENTO DE INFECçõES"<D>. Uso de um composto da fórmula (I) para o tratamento profilático e terapêutico de processos infecciosos no homem e nos animais, provocados por bactérias, fungos ou parasitas, e como fungicida, bactericida ou herbicida em plantas.
BR9915605-9A 1998-11-25 1999-11-20 Uso de derivados do ácido fosfonofórmico para o tratamento de infecções BR9915605A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854310A DE19854310A1 (de) 1998-11-25 1998-11-25 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
PCT/EP1999/008964 WO2000030653A2 (de) 1998-11-25 1999-11-20 Verwendung von phosphonoameisensäurederivaten zur behandlung von infektionen

Publications (1)

Publication Number Publication Date
BR9915605A true BR9915605A (pt) 2001-08-14

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915605-9A BR9915605A (pt) 1998-11-25 1999-11-20 Uso de derivados do ácido fosfonofórmico para o tratamento de infecções

Country Status (16)

Country Link
EP (1) EP1133302A2 (pt)
JP (1) JP2002530343A (pt)
CN (1) CN1328464A (pt)
AP (1) AP2001002164A0 (pt)
AU (1) AU1859100A (pt)
BR (1) BR9915605A (pt)
CA (1) CA2352511A1 (pt)
CZ (1) CZ20011819A3 (pt)
DE (1) DE19854310A1 (pt)
EA (1) EA200100585A1 (pt)
IL (1) IL142775A0 (pt)
NO (1) NO20012540L (pt)
OA (1) OA11718A (pt)
PL (1) PL348354A1 (pt)
TR (1) TR200101431T2 (pt)
WO (1) WO2000030653A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1408984T3 (da) * 2001-07-20 2009-02-09 Bioagency Ag Organofosforforbindelser til aktivering af gamma/delta T celler
JP2006520374A (ja) * 2003-03-14 2006-09-07 エピスタム リミテッド 非ウィルス性上皮損傷の治療および/または予防
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (zh) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 白桦脂酸在制备抗真菌生物被膜药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (en) * 1993-11-05 1995-05-11 Aktiebolaget Astra Novel amino acid derivatives
SE9604582D0 (sv) * 1996-12-13 1996-12-13 Astra Ab Novel compounds
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
DE19859668A1 (de) * 1998-06-24 1999-12-30 Hassan Jomaa Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen

Also Published As

Publication number Publication date
NO20012540L (no) 2001-07-24
WO2000030653A3 (de) 2000-11-16
TR200101431T2 (tr) 2001-10-22
OA11718A (en) 2005-01-26
EP1133302A2 (de) 2001-09-19
CZ20011819A3 (cs) 2001-12-12
CA2352511A1 (en) 2000-06-02
AP2001002164A0 (en) 2001-06-30
NO20012540D0 (no) 2001-05-23
EA200100585A1 (ru) 2002-04-25
PL348354A1 (en) 2002-05-20
CN1328464A (zh) 2001-12-26
IL142775A0 (en) 2002-03-10
DE19854310A1 (de) 2000-06-29
JP2002530343A (ja) 2002-09-17
WO2000030653A2 (de) 2000-06-02
AU1859100A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
ES2188795T3 (es) Agentes antimicrobianos benzoxacina.
YU2201A (sh) Fosfororganska jedinjenja i njihova upotreba
WO2000044359A3 (de) Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
BR0209430A (pt) Compostos heterocìclicos
WO2000066094A3 (de) Verwendung von verbindungen mit einem stickstoff-sauerstoff-heterocyclus als antiinfektiöse mittel
BR9915605A (pt) Uso de derivados do ácido fosfonofórmico para o tratamento de infecções
EA200501521A1 (ru) Аллицин
WO2000044358A3 (de) Verwendung von phosphororganischen verbindungen zur prophylaktischen und therapeutischen behandlung von infektionen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
BR0206262A (pt) Composição antimicrobiana lìquida, uso da mesma, e, método de exterminar ou eliminar vìrus ou esporos
ES2096592T3 (es) Proceso para la desinfeccion de tejido musculoesqueletico y tejidos asi preparados.
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
BR9814815A (pt) Agente para o tratamento de leishmaniose com um derivado de glicopiranose como ingrediente eficaz

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.